Trustmark National Bank Trust Department’s Elevance Health ELV Stock Holding History

Trustmark National Bank Trust Department’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,629	Closed	-$724K	–	249
2023 Q2	$724K	Sell	1,629 -1,048	-39%	-$483K	0.07%	163
2023 Q1	$1.23M	Sell	2,677 -1,162	-30%	-$553K	0.11%	133
2022 Q4	$1.97M	Buy	3,839 +4	+0.1%	+$2.03K	0.18%	102
2022 Q3	$1.74M	Sell	3,835 -220	-5%	-$105K	0.17%	102
2022 Q2	$1.96M	Buy	4,055 +213	+6%	+$105K	0.18%	96
2022 Q1	$1.89M	Buy	3,842 +2,802	+269%	+$1.28M	0.15%	107
2021 Q4	$482K	Hold	1,040	–	–	0.04%	193
2021 Q3	$388K	Hold	1,040	–	–	0.03%	202
2021 Q2	$397K	Sell	1,040 -12	-1%	-$4.59K	0.03%	197
2021 Q1	$378K	Buy	1,052 +12	+1%	+$3.86K	0.03%	201
2020 Q4	$334K	Hold	1,040	–	–	0.03%	201
2020 Q3	$279K	Sell	1,040 -207	-17%	-$55.7K	0.03%	201
2020 Q2	$328K	Buy	+1,247	New	+$333K	0.03%	188
2019 Q3	–	Sell	-265	Closed	-$75K	–	334
2019 Q2	$75K	Hold	265	–	–	0.01%	301
2019 Q1	$76K	Hold	265	–	–	0.01%	295
2018 Q4	$70K	Sell	265 -55	-17%	-$15.1K	0.01%	287
2018 Q3	$88K	Buy	+320	New	+$83.1K	0.01%	293
2016 Q1	–	Sell	-5,904	Closed	-$823K	–	339
2015 Q4	$823K	Sell	5,904 -12,512	-68%	-$1.72M	0.11%	147
2015 Q3	$2.58M	Sell	18,416 -32	-0.2%	-$4.81K	0.36%	65
2015 Q2	$3.03M	Sell	18,448 -697	-4%	-$111K	0.41%	55
2015 Q1	$2.96M	Sell	19,145 -4,159	-18%	-$592K	0.39%	57
2014 Q4	$2.93M	Sell	23,304 -1,018	-4%	-$126K	0.4%	58
2014 Q3	$2.91M	Sell	24,322 -2,392	-9%	-$274K	0.41%	58
2014 Q2	$2.88M	Buy	26,714 +520	+2%	+$53.6K	0.33%	61
2014 Q1	$2.61M	Buy	26,194 +6,497	+33%	+$588K	0.3%	60
2013 Q4	$1.82M	Buy	19,697 +11,082	+129%	+$985K	0.21%	90
2013 Q3	$720K	Buy	+8,615	New	+$738K	0.09%	169

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Trustmark National Bank Trust Department's ELV Position: Q3 2023 in Review

Trustmark National Bank Trust Department sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 1,629 shares — an estimated $724K sold.

Trustmark National Bank Trust Department first reported a position in ELV in Q3 2013 and held it in 27 quarters. The position peaked at $3.03M in Q2 2015. 1,526 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

Trustmark National Bank Trust Department reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
Trustmark National Bank Trust Department sold 1,629 Elevance Health shares in Q3 2023, an estimated $724K.
Trustmark National Bank Trust Department first reported a position in Elevance Health in Q3 2013 and held it in 27 quarters.
Trustmark National Bank Trust Department's Elevance Health position peaked at $3.03M in Q2 2015.
1,526 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Trustmark National Bank Trust Department's 13F filing for Q3 2023, filed 13 Nov 2023.